M. Yıldız, F. Sultanova, H. S. Özger, Merve Büyükkörük, K. Erbay, Ü. Gaygısız, A. Tufan, Ö. Gülbahar, Fatma Zehra Özcan, Nazlı Elif Kuscu, Deniz Gazioglu, Beyza Çiftçi, F. Sen, E. Senol, Kenan Hızal, Özlem Güzel Tunçcan, Pınar Aysert Yıldız, Yeşim Yıldız, M. Dizbay
{"title":"托珠单抗治疗对重症COVID-19肺炎患者预后的影响","authors":"M. Yıldız, F. Sultanova, H. S. Özger, Merve Büyükkörük, K. Erbay, Ü. Gaygısız, A. Tufan, Ö. Gülbahar, Fatma Zehra Özcan, Nazlı Elif Kuscu, Deniz Gazioglu, Beyza Çiftçi, F. Sen, E. Senol, Kenan Hızal, Özlem Güzel Tunçcan, Pınar Aysert Yıldız, Yeşim Yıldız, M. Dizbay","doi":"10.36519/idcm.2021.51","DOIUrl":null,"url":null,"abstract":"Background: This study aimed to evaluate the impact of tocilizumab treatment on clinical improvement in severe COVID-19 cases and the factors affecting clinical response","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia\",\"authors\":\"M. Yıldız, F. Sultanova, H. S. Özger, Merve Büyükkörük, K. Erbay, Ü. Gaygısız, A. Tufan, Ö. Gülbahar, Fatma Zehra Özcan, Nazlı Elif Kuscu, Deniz Gazioglu, Beyza Çiftçi, F. Sen, E. Senol, Kenan Hızal, Özlem Güzel Tunçcan, Pınar Aysert Yıldız, Yeşim Yıldız, M. Dizbay\",\"doi\":\"10.36519/idcm.2021.51\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: This study aimed to evaluate the impact of tocilizumab treatment on clinical improvement in severe COVID-19 cases and the factors affecting clinical response\",\"PeriodicalId\":11964,\"journal\":{\"name\":\"European Journal of Clinical Microbiology and Infectious Diseases\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Clinical Microbiology and Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36519/idcm.2021.51\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology and Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36519/idcm.2021.51","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia
Background: This study aimed to evaluate the impact of tocilizumab treatment on clinical improvement in severe COVID-19 cases and the factors affecting clinical response
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
